Senores Pharmaceuticals Limited — Important, 22-04-2025: Updates

Senores Pharmaceuticals has provided an update regarding its acquisition of 8,454 equity shares from certain shareholders of Havix Group Inc. Out of these, 7,914 shares have been successfully acquired, while the acquisition of 540 shares is still pending due to required approvals from the Reserve Bank of India (RBI). Consequently, the time frame for completing this acquisition has been extended by an additional 60 days. Investors should monitor this development closely, as any delays or changes in regulatory approvals could impact the acquisition’s finalization and the company's strategic positioning.